Sunshine Biopharma
SBFM · NASDAQ
$0.22−$0.0218 (−9.02%)TodayMarket closed ·
Prev close $0.2418
Who owns SBFM
Largest institutional holders, from their latest 13F filings
The 10 largest institutions hold 14.4% of SBFM’s shares.
- L1 Global Manager Pty Limited4.2%
- Bigger Capital Funds, LP3.4%
- District 2 Capital LP3.4%
- Natan (David)2.9%
- Next 6 largest institutions0.7%
- All other shareholders85.6%
| Holder | Shares | % of shares |
|---|---|---|
| L1 Global Manager Pty Limited | 100.00K | 4.18% |
| Bigger Capital Funds, LP | 80.50K | 3.37% |
| District 2 Capital LP | 80.50K | 3.37% |
| Natan (David) | 68.30K | 2.86% |
| Jane Street Capital, L.L.C. | 14.97K | 0.63% |
| Morgan Stanley Smith Barney LLC | 385 | 0.02% |
| Chamoun (Malek) | 185 | 0.01% |
| SBI Securities Co., Ltd. | 162 | 0.01% |
| Sebaaly (Camille) | 6 | 0.00% |
| Slilaty (Steve N) | 6 | 0.00% |
Insider trades
Form 4 filings by officers, directors and large holders
Insiders made no open-market buys or sales of SBFM in the last 6 months.
| Insider | Type | Shares | Value |
|---|---|---|---|
| NATAN DAVID | Award | 58.30K | — |
Short interest
Settled Sep 30, 2026
- Shares short
- 131.48K
- Days to cover
- 1.00
- % of shares outstanding
- 5.50%
- Average daily volume
- 161.72K
- Change since last report
- +461.6%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.